Explore the words cloud of the ELFBAD project. It provides you a very rough idea of what is the project "ELFBAD" about.
The following table provides information about the project.
Coordinator |
UNIVERSITY OF NEWCASTLE UPON TYNE
Organization address contact info |
Coordinator Country | United Kingdom [UK] |
Total cost | 2˙428˙621 € |
EC max contribution | 2˙428˙621 € (100%) |
Programme |
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC)) |
Code Call | ERC-2014-ADG |
Funding Scheme | ERC-ADG |
Starting year | 2015 |
Duration (year-month-day) | from 2015-10-01 to 2020-09-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | UNIVERSITY OF NEWCASTLE UPON TYNE | UK (NEWCASTLE UPON TYNE) | coordinator | 2˙428˙621.00 |
Despite the clear importance and multiple functions of the bacterial cell wall, many bacteria appear to be able to switch into a cell wall deficient or “L-form” state. L-forms are very heterogeneous in size and shape and generally require osmotic stabilisers, such as 0.5 M sucrose, for viability. However, by lacking the requirement for a cell wall, L-forms are completely resistant to common cell wall antibiotics, such as β-lactams, and they are probably protected from some elements of innate immune recognition. L-forms are therefore of potential interest in relation to their possible involvement in human disease. They have often been reported in clinical specimens obtained from patients with recurrent or persistent infections or on long term prophylaxis with β-lactam antibiotics. Unfortunately, until recently, most of the work on L-forms had been done in the pre-molecular era, when it was difficult to characterise the L-forms and particularly to identify their origins and relationship with other resident pathogenic bacteria. Recently, several labs have revisited the L-form issue and started to apply modern molecular and cell biological methods. The proposal is divided into three Themes: • Improve our understanding of key features of the L-forms of our best characterised model system, B. subtilis, including both basic science and possible biotechnological applications. • Extend our analysis of basic L-form biology into several diverse bacterial systems, of relevance to both biotechnology and infectious disease. • Explore in detail the possible clinical relevance of L-forms, aiming to identify specific clinical situations in which they are relevant or, at least, to establish model systems in which the interactions between L-form and mammalian systems can be studied.
year | authors and title | journal | last update |
---|---|---|---|
2016 |
Romain Mercier, Yoshikazu Kawai, Jeff Errington Wall proficient E. coli capable of sustained growth in the absence of the Z-ring division machine published pages: 16091, ISSN: 2058-5276, DOI: 10.1038/nmicrobiol.2016.91 |
Nature Microbiology 1/8 | 2019-07-05 |
2016 |
Jeff Errington, Katarzyna Mickiewicz, Yoshikazu Kawai, Ling Juan Wu L-form bacteria, chronic diseases and the origins of life published pages: 20150494, ISSN: 0962-8436, DOI: 10.1098/rstb.2015.0494 |
Philosophical Transactions of the Royal Society B: Biological Sciences 371/1707 | 2019-07-05 |
2017 |
Henrik Strahl, Jeff Errington Bacterial Membranes: Structure, Domains, and Function published pages: 519-538, ISSN: 0066-4227, DOI: 10.1146/annurev-micro-102215-095630 |
Annual Review of Microbiology 71/1 | 2019-07-05 |
2018 |
Yoshikazu Kawai, Katarzyna Mickiewicz, Jeff Errington Lysozyme Counteracts β-Lactam Antibiotics by Promoting the Emergence of L-Form Bacteria published pages: 1038-1049.e10, ISSN: 0092-8674, DOI: 10.1016/j.cell.2018.01.021 |
Cell 172/5 | 2019-07-05 |
2017 |
Kaveh Emami, Aurelie Guyet, Yoshikazu Kawai, Jenny Devi, Ling J. Wu, Nick Allenby, Richard A. Daniel, Jeff Errington RodA as the missing glycosyltransferase in Bacillus subtilis and antibiotic discovery for the peptidoglycan polymerase pathway published pages: 16253, ISSN: 2058-5276, DOI: 10.1038/nmicrobiol.2016.253 |
Nature Microbiology 2 | 2019-07-05 |
2017 |
Jeff Errington Cell wall-deficient, L-form bacteria in the 21st century: a personal perspective published pages: 287-295, ISSN: 0300-5127, DOI: 10.1042/BST20160435 |
Biochemical Society Transactions 45/2 | 2019-07-05 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ELFBAD" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ELFBAD" are provided by the European Opendata Portal: CORDIS opendata.